After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
In 2006, the US Food and Drug Administration issued an advisory that warned of the risk for serotonin syndrome with concomitant use of triptans and certain antidepressants. In a recent study, researchers...
